title: Cell surface molecules of human melanoma. Immunohistochemical analysis of the gp57, GD3, and mel-CSPG antigenic systems.
abstract: The rapidly expanding list of monoclonal antibodies (MAbs) to human cell surface antigens provides reagents to probe the biology of malignant melanoma and to develop new diagnostic and therapeutic approaches to this disease. The criteria used to select MAb-defined antigens as targets for passive immunotherapy or immunolocalization of melanoma include: 1) consistent antigen expression in melanomas, 2) restricted antigen distribution in normal tissues and nonmelanocytic tumors, and 3) cytotoxic activity of the MAb or MAb conjugates. The present study examined the tissue distribution of three prototype melanoma cell surface antigens, the Mr 57,000 glycoprotein (gp57) recognized by MAb A42, the GD3 ganglioside, and the mel-CSPG chondroitin sulfate proteoglycan. The avidin-biotin immunoperoxidase method was used to examine a large panel of normal tissues and over 150 malignant tumors. It was found that A42 has a highly restricted distribution in normal tissues and is expressed in subsets of melanomas and nonmelanocytic tumors. It was also found that GD3 and mel-CSPG are more widely distributed in normal tissues and among tumors than was thought previously. These immunohistochemical patterns provide an essential data base to evaluate the ongoing clinical trials employing MAbs to GD3 and mel-CSPG for the therapy and immunolocalization of melanomas, and they identify gp57 as a potential marker for subsets of normal and transformed melanocytic cells.
authors.affiliation: Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.
authors.forename: P
authors.initials: P
authors.lastname: Garin-Chesa
authors.forename: H R
authors.initials: HR
authors.lastname: Beresford
authors.forename: A
authors.initials: A
authors.lastname: Carrato-Mena
authors.forename: H F
authors.initials: HF
authors.lastname: Oettgen
authors.forename: L J
authors.initials: LJ
authors.lastname: Old
authors.forename: M R
authors.initials: MR
authors.lastname: Melamed
authors.forename: W J
authors.initials: WJ
authors.lastname: Rettig
mesh_terms: D053674:Aggrecans; D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm / Q000032:analysis; D000954:Antigens, Surface / Q000032:analysis*; D002462:Cell Membrane / Q000276:immunology / Q000378:metabolism; D016326:Extracellular Matrix Proteins; D005732:Gangliosides / Q000032:analysis*; D006023:Glycoproteins / Q000032:analysis*; D006801:Humans; D007150:Immunohistochemistry; D037181:Lectins, C-Type; D008545:Melanoma / Q000276:immunology / Q000378:metabolism* / Q000648:ultrastructure; D008562:Membrane Glycoproteins / Q000032:analysis*; D011509:Proteoglycans
chemical_list: D053674:Aggrecans; D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D016326:Extracellular Matrix Proteins; D005732:Gangliosides; D006023:Glycoproteins; D037181:Lectins, C-Type; D008562:Membrane Glycoproteins; D011509:Proteoglycans; C026226:ganglioside, GD3